The collaboration enables MGI to leverage Swiss Rockets’ strong R&D capabilities and established presence in Europe and the U.S. to commercialise CoolMPS™...
It enables non-invasive, high-resolution in vivo analysis of the entire brain, significantly improving precision in both space and time...
Pen-needle stability and comfort directly influence user confidence and adherence...
The successful filing of the XJ LLM represents a milestone in Fangzhou’s AI-enabled chronic disease management ecosystem...
Through this collaboration, Fangzhou’s AI Health Manager will offer personalised care guidance and monitoring...
The 52-week data from these two Phase III clinical trials demonstrate the durability of response and highlight the comprehensive long-term clinical benefits of HTD1801 in patients with T2DM...
This collaboration marks Everest’s strategic expansion into ophthalmology, a high-potential “blue-ocean” therapeutic area...
The strategic partnership is set to fully unlock the patent value and productisation capabilities of CoolMPS, complementing MGI's tried-and-true StandardMPS technology ...
China has designated weight management as a national health priority, integrating it into the Healthy China 2030 strategy through a series of government-led initiatives...
EVM14, an off-the-shelf therapeutic mRNA cancer vaccine, was developed based on Everest Medicines' proprietary mRNA platform...
